Melar Acquisition Corp. I - Unit (MACIU)
Community market perspectives and discussion for Melar Acquisition Corp. I - Unit (NASDAQ: MACIU).
Community market perspectives and discussion for Melar Acquisition Corp. I - Unit (NASDAQ: MACIU).
On our desk, the massive $131.5 million redemption wave tied to the December 2026 extension vote is the main talking point. With 12,076,077 Class A Public Shares redeemed, the remaining public float is slashed to just over 3.9 million shares. While a tight float can trigger explosive moves on low volume, the underlying capital drain from the trust account down to $42.9 million introduces severe structural fragility heading into the Everli merger.
From a structuring perspective, the S-4 filing details a complex transaction where New Melar will be heavily controlled by Everli's 30-vote shares, while the merger consideration values Everli at an aggregate of $180 million plus bridge financing and equity investments at $10.00 per share. Analysts need to carefully parse the dual-class share architecture—splitting between one-vote Class A and 30-vote Class B—when evaluating post-merger governance dynamics.
Watching the 10-Q and 8-K filings closely, the operational picture reveals a pre-revenue SPAC struggling with a $1.77 million working capital deficit. Even though net income for 2Q 2026 landed at $720,200 with an EPS of $0.04, this is down from $1.15 million and $0.07 in the prior-year period. The financial cushion relies heavily on the sponsor's affiliate Everli injecting up to $78,478 monthly to fund trust extensions.
From a market sentiment standpoint, social streams and message volumes remain fairly subdued, though MACIU trades around $11.20 with a market cap of $242.16M and a P/E ratio sitting near 60.94. Participants are largely waiting for definitive closing dates on the Everli Global merger rather than chasing the unit's low-volume spikes.
As a risk manager, I am flagging the going concern notes alongside the heavy redemptions. The reduction of the Trust Account from $171.4 million to $42.9 million means the combined entity will have considerably less cash trust proceeds available unless additional PIPE or bridge financing successfully closes alongside the Nevada domestication.
Explore plasma cleansing, somatic organ swaps, and BCI.